Profil
Herr Michael Wolff Jensen ist Chairman bei Vicore Pharma Holding AB, Chief Executive Officer bei Miwo Invest ApS, Chairman bei Xspray Pharma AB, Chairman bei Ascendis Pharma Endocrinology Division A/S, Chairman, Chief Legal Officer & Senior VP bei Ascendis Pharma A/S, Chairman bei Ascendis Pharma Bone Diseases A/S und Chairman bei Ascendis Pharma Growth Disorders AS. Er ist Mitglied des Board of Directors bei Visen Pharmaceuticals (Shanghai) Co. Ltd. Herr Jensen war zuvor als Chairman bei Eurocine Vaccines AB, als Head-France Partnerships bei DONG Energy A/S, als Chief Financial Officer & Executive Vice President bei LifeCycle Pharma A/S, als Chief Financial Officer & Senior Vice President bei Genmab A/S, als President & Chief Executive Officer bei EMF Industries A/S, als Chairman bei MWJ Invest AB, als Chairman bei Paradis A/S und als Chairman bei Vanx ApS tätig. Er war auch im Vorstand von Azanta A/S. Er erhielt seinen Abschluss an der Universität von Kopenhagen.
Aktive Positionen von Michael Wolff Jensen
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENDIS PHARMA A/S | General Counsel | 01.06.2013 |
Miwo Invest ApS
Miwo Invest ApS Miscellaneous Commercial ServicesCommercial Services Provides business and other management consulting services | Vorstandsvorsitzender | 28.01.2014 |
Ascendis Pharma Ophthalmology Division A/S | Vorsitzender | - |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Direktor/Vorstandsmitglied | - |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Vorsitzender | - |
Ascendis Pharma Growth Disorders AS | Vorsitzender | - |
Ascendis Pharma Bone Diseases A/S | Vorsitzender | - |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Direktor/Vorstandsmitglied | 01.05.2021 |
Ascendis Pharma Endocrinology Division A/S
Ascendis Pharma Endocrinology Division A/S Pharmaceuticals: MajorHealth Technology Manufactures endocrine pharmaceutical products | Vorsitzender | 29.06.2012 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Michael Wolff Jensen
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Michael Wolff Jensen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 23 |
|---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for prevention of organ rejection in kidney transplant patients | Health Technology |
Eurocine Vaccines AB
Eurocine Vaccines AB Pharmaceuticals: MajorHealth Technology Develops nasal influenza vaccines | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Ørsted A/S
Ørsted A/S Electric UtilitiesUtilities Develops, constructs and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities and bioenergy plants | Utilities |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Xspray Pharma AB
Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
Paradis A/S | |
EMF Industries A/S | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
MWJ Invest AB | |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
Miwo Invest ApS
Miwo Invest ApS Miscellaneous Commercial ServicesCommercial Services Provides business and other management consulting services | Commercial Services |
Vanx ApS | |
Ascendis Pharma Endocrinology Division A/S
Ascendis Pharma Endocrinology Division A/S Pharmaceuticals: MajorHealth Technology Manufactures endocrine pharmaceutical products | Health Technology |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Health Technology |
Ascendis Pharma Bone Diseases A/S | |
Ascendis Pharma Ophthalmology Division A/S | |
Ascendis Pharma Oncology Division A/S | |
Ascendis Pharma Growth Disorders AS | |
VISEN Pharmaceuticals
VISEN Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes paradigm-shifting endocrine therapies | Health Technology |
















